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Chemical biology is an interdisciplinary field of study that is often defined as “chemistry-
initiated biology.” As biological processes all stem from chemical events, it should be possible 
to understand or manipulate biological events by using chemistry. Our laboratory has been 
discovering or designing unique organic molecules that modulate fundamental processes in 
human cells. Such synthetic organic molecules often serve as tools for basic cell biology. 
Discovery or design of small molecules with unique biological activity permits small- molecule initiated exploration of 
complex cellular events. Our mission is to create a new world of bioactive synthetic molecules: their new way to use, 
their new shapes, and their new sizes. We hope to open new avenues for small-molecule applications in a range of fields, 
including future concepts in drug discovery and use of small molecules for cell therapy.
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Small Molecule-induced Clustering of 
Heparan Sulfate Promotes Cell Adhesion
Adhesamine is an organic small molecule that promotes 
adhesion and growth of cultured human cells by binding 
selectively to heparan sulfate on the cell surface. The 
 Uesugi research group combined chemical, physicochemi-
cal, and cell biological experiments, using adhesamine and 
its analogues, to examine the mechanism by which this 
dumbbell-shaped, non-peptidic molecule induces physio-
logically relevant cell adhesion. The results suggest that 
multiple adhesamine molecules cooperatively bind to 
 heparan sulfate and induce its assembly, promoting clus-
tering of heparan sulfate-bound syndecan-4 on the cell sur-
face. A pilot study showed that adhesamine improved the 
viability and attachment of transplanted cells in mice. 
Further studies of adhesamine and other small molecules 
could lead to the design of assembly-inducing molecules 
for use in cell biology and cell therapy.
Small-molecule Inhibitors of SREBP 
Activation–potential for New Treatment of 
Metabolic Disorders
Sterol regulatory element-binding proteins (SREBPs) 
are transcriptional factors that control lipid and cholesterol 
metabolism. Activation of SREBPs in response to a decrease 
in cellular sterols results in acceleration of the synthesis of 
fatty acids, triglycerides, and cholesterol. Aberrant SREBP 
activity has been linked to metabolic disease states, such 
as obesity, fatty liver, insulin resistance, hyperlipidemia, 
and atherosclerosis. Thus, inhibition of SREBP activation is 
a potential therapeutic approach to treating metabolic 
disorders. Our laboratory recently discovered a number of 
inhibitors of SREBP activation, including fatostatin and 
FGH10019. Our analysis indicates that these two synthetic 
molecules exert their biological activities by directly 
interacting with SCAP (SREBP cleavage-activating protein).
